Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RAPP Rapport Therapeutics, Inc.

交易中 05-02 13:47:01 EDT

11.94

+0.47

+4.05%

最高12.31	最低11.74	成交量2.58万
今开11.76	昨收11.47	日振幅5.01%
总市值4.36亿	流通市值1.76亿	总股本3,650万
成交额30.78万	换手率0.18%	流通股本1,475万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":11.935,"timestamp":1746207942070,"preClose":11.47,"halted":0,"volume":25835,"delay":0,"floatShares":14750261,"shares":36496437,"eps":-3.775953,"marketStatus":"交易中","change":0.465,"latestTime":"05-02 13:47:01 EDT","open":11.76,"high":12.3101,"low":11.735,"amount":307769.97818,"amplitude":0.050139,"askPrice":11.99,"askSize":44,"bidPrice":11.88,"bidSize":459,"shortable":3,"etf":0,"ttmEps":-3.775953,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746216000000},"marketStatusCode":2,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":11.47,"preHourTrading":{"tag":"盘前","latestPrice":11.47,"preClose":11.47,"latestTime":"04:22 EDT","volume":4,"amount":46.32,"timestamp":1746174148162},"postHourTrading":{"tag":"盘后","latestPrice":11.47,"preClose":11.47,"latestTime":"16:20 EDT","volume":912,"amount":10460.64,"timestamp":1746130802623},"volumeRatio":0.255038,"impliedVol":0.7198,"impliedVolPercentile":0.5545},"requestUrl":"/m/hq/s/RAPP","defaultTab":"news","newsList":[{"id":"2532767844","title":"Rapport Therapeutics, Inc.盘中异动 大幅上涨7.32%报12.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532767844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532767844?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:33","pubTimestamp":1746192814,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时33分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨7.32%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Polyrizon Ltd.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Adaptive Biotechnologies Corporation涨幅较大，Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为206.19%、155.87%、60.03%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Polyrizon Ltd.、Adaptive Biotechnologies Corporation，振幅分别为67.34%、37.45%、18.34%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213335974d6531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213335974d6531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RAPP","BK4007","LENZ"],"gpt_icon":0},{"id":"2532619330","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨5.20%报11.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532619330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532619330?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:53","pubTimestamp":1746035610,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日01时53分，Rapport Therapeutics, Inc.股票出现波动，股价快速上涨5.20%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Abeona Therapeutics Inc.涨幅较大，Purple Biotech Ltd、Processa Pharmaceuticals, Inc.、Regulus Therapeutics Inc.较为活跃，换手率分别为163.79%、37.06%、35.99%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Abeona Therapeutics Inc.、Osr Holdings Inc C/Wts 09/02/2028 ，振幅分别为64.00%、37.52%、34.25%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501015330974bd277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501015330974bd277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2530875132","title":"Rapport Therapeutics, Inc.盘中异动 急速上涨7.06%报11.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530875132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530875132?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:43","pubTimestamp":1745847829,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时43分，Rapport Therapeutics, Inc.股票出现波动，股价快速上涨7.06%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1601.08%、344.16%、66.30%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Protara Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为27.39%、22.69%、22.50%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214349a46a91b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214349a46a91b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","RAPP"],"gpt_icon":0},{"id":"2530139163","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.41%报10.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530139163?lang=zh_cn&edition=full","pubTime":"2025-04-26 01:39","pubTimestamp":1745602790,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日01时39分，Rapport Therapeutics, Inc.股票出现异动，股价大幅下跌5.41%。截至发稿，该股报10.50美元/股，成交量2.4875万股，换手率0.07%，振幅6.67%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426013950974552ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426013950974552ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RAPP","LENZ","BK4139"],"gpt_icon":0},{"id":"2530966293","title":"Rapport Therapeutics, Inc.盘中异动 下午盘大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530966293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530966293?lang=zh_cn&edition=full","pubTime":"2025-04-25 02:10","pubTimestamp":1745518244,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日02时10分，Rapport Therapeutics, Inc.股票出现异动，股价大幅下跌5.01%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425021045a465b760&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425021045a465b760&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","RAPP","BK4139"],"gpt_icon":0},{"id":"2529878175","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨6.17%报11.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529878175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529878175?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:50","pubTimestamp":1745329813,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时50分，Rapport Therapeutics, Inc.股票出现波动，股价急速拉升6.17%。截至发稿，该股报11.02美元/股，成交量3840股，换手率0.01%，振幅4.34%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422215013a6c3df4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422215013a6c3df4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2527273425","title":"Rapport Therapeutics, Inc.盘中异动 下午盘急速下跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527273425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527273425?lang=zh_cn&edition=full","pubTime":"2025-04-16 01:30","pubTimestamp":1744738231,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日01时30分，Rapport Therapeutics, Inc.股票出现波动，股价快速下跌5.18%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Mural Oncology Plc、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃，换手率分别为1396.53%、965.04%、253.86%，振幅较大的相关个股有Skye Bioscience, Inc.、Mural Oncology Plc、Dogwood Therapeutics, Inc.，振幅分别为171.53%、97.08%、91.33%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041601303194d65941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041601303194d65941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2527136271","title":"Rapport Therapeutics, Inc.盘中异动 快速上涨5.51%报9.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527136271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527136271?lang=zh_cn&edition=full","pubTime":"2025-04-15 00:44","pubTimestamp":1744649074,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日00时44分，Rapport Therapeutics, Inc.股票出现异动，股价快速上涨5.51%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.02%。其相关个股中，Third Harmonic Bio, Inc.、Theratechnologies Inc.、Metsera, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为709.10%、650.15%、330.08%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为72.35%、48.91%、45.11%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415004434a458b422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415004434a458b422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2526113276","title":"Rapport Therapeutics, Inc.盘中异动 快速上涨5.64%报9.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526113276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526113276?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:49","pubTimestamp":1744393759,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时49分，Rapport Therapeutics, Inc.股票出现波动，股价快速拉升5.64%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。消息层面，截至01时49分，《Rapport Therapeutics获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价28.00美元。》资讯为影响Rapport Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014919aa2c6d28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014919aa2c6d28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"1126656451","title":"Rapport Therapeutics 2024财年第四季度每股亏损$(0.57)，优于预期$(0.62)，年末现金、现金等价物和短期投资达3.053亿美元，预计可支持运营至2026年底","url":"https://stock-news.laohu8.com/highlight/detail?id=1126656451","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126656451?lang=zh_cn&edition=full","pubTime":"2025-03-11 19:43","pubTimestamp":1741693381,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics 报告季度每股亏损$，优于分析师预期的$，超出8.06%。与去年同期每股亏损$相比，这是一个92.88%的增长。以上内容来自Benzinga Earnings专栏，原文如下：Rapport $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 8.06 percent. This is a 92.88 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","LENZ"],"gpt_icon":0},{"id":"2518274695","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.24%报8.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518274695?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615239,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Rapport Therapeutics, Inc.股票出现波动，股价急速下跌5.24%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3087.26%、661.78%、287.22%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2517163165","title":"Rapport Therapeutics, Inc.盘中异动 快速跳水5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517163165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517163165?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271504,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Rapport Therapeutics, Inc.股票出现波动，股价快速下挫5.54%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Exicure, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为946.46%、104.14%、48.84%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223145abeb7784&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223145abeb7784&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","RAPP"],"gpt_icon":0},{"id":"2516340206","title":"Rapport Therapeutics, Inc.盘中异动 快速跳水5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516340206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516340206?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012315,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Rapport Therapeutics, Inc.股票出现异动，股价急速跳水5.78%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.17%、23.41%、22.45%，振幅较大的相关个股有Entero Therapeutics Inc.、Cibus, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为11.70%、9.55%、9.35%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231559637ac09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231559637ac09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2516937063","title":"Rapport Therapeutics, Inc.盘中异动 快速跳水5.03%报10.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516937063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516937063?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:06","pubTimestamp":1740765996,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时06分，Rapport Therapeutics, Inc.股票出现波动，股价急速下挫5.03%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301020636a2583559&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301020636a2583559&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2514862502","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.09%报11.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862502?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:13","pubTimestamp":1740600826,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时13分，Rapport Therapeutics, Inc.股票出现波动，股价急速跳水5.09%。截至发稿，该股报11.18美元/股，成交量21.0055万股，换手率0.57%，振幅8.32%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270413469893e853&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270413469893e853&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2514003019","title":"Rapport Therapeutics, Inc.盘中异动 快速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514003019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514003019?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:23","pubTimestamp":1740500639,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时23分，Rapport Therapeutics, Inc.股票出现异动，股价快速下挫5.06%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1331.76%、1114.37%、902.45%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260023599892645f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260023599892645f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RAPP"],"gpt_icon":0},{"id":"2514708900","title":"Rapport Therapeutics, Inc.盘中异动 急速拉升5.52%报13.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514708900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514708900?lang=zh_cn&edition=full","pubTime":"2025-02-25 03:54","pubTimestamp":1740426886,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时54分，Rapport Therapeutics, Inc.股票出现波动，股价快速拉升5.52%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为324.89%、139.35%、40.20%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035446989134fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035446989134fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RAPP"],"gpt_icon":0},{"id":"2512353514","title":"Rapport Therapeutics, Inc.盘中异动 下午盘大幅下跌5.13%报13.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512353514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512353514?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:57","pubTimestamp":1739991465,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时57分，Rapport Therapeutics, Inc.股票出现波动，股价急速下跌5.13%。截至发稿，该股报13.32美元/股，成交量4.4918万股，换手率0.12%，振幅8.90%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220025745abd52e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220025745abd52e7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RAPP","LENZ","BK4139"],"gpt_icon":0},{"id":"2512169270","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.03%报15.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169270?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:17","pubTimestamp":1739891876,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时17分，Rapport Therapeutics, Inc.股票出现波动，股价急速下挫5.03%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Allogene Therapeutics, Inc.、Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为353.35%、135.13%、128.47%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Allogene Therapeutics, Inc.，振幅分别为148.75%、51.40%、50.49%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182317569627a049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182317569627a049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RAPP"],"gpt_icon":0},{"id":"2511691391","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨5.23%报16.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511691391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511691391?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:55","pubTimestamp":1739544901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时55分，Rapport Therapeutics, Inc.股票出现异动，股价大幅上涨5.23%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2034.72%、525.34%、439.22%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、40.35%、33.28%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225501962320e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225501962320e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","RAPP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rapportrx.com","stockEarnings":[{"period":"1week","weight":0.0333},{"period":"1month","weight":0.1998},{"period":"3month","weight":-0.301},{"period":"6month","weight":-0.5341},{"period":"1year","weight":-0.3253},{"period":"ytd","weight":-0.3534}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.0045},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1162},{"period":"ytd","weight":-0.0471}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rapport Therapeutics, Inc.于2022年2月根据特拉华州法律注册成立，名称为Precision Neuroscience NewCo, Inc.，并于2022年10月更名为Rapport Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，专注于通过发现和开发用于中枢神经系统（“CNS”）疾病患者的转化小分子药物，成为精确神经科学的领导者。","exchange":"NASDAQ","name":"Rapport Therapeutics, Inc.","nameEN":"Rapport Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rapport Therapeutics, Inc.,RAPP,Rapport Therapeutics, Inc.股票,Rapport Therapeutics, Inc.股票老虎,Rapport Therapeutics, Inc.股票老虎国际,Rapport Therapeutics, Inc.行情,Rapport Therapeutics, Inc.股票行情,Rapport Therapeutics, Inc.股价,Rapport Therapeutics, Inc.股市,Rapport Therapeutics, Inc.股票价格,Rapport Therapeutics, Inc.股票交易,Rapport Therapeutics, Inc.股票购买,Rapport Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}